Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAO Group Inc PAOG

Healthcare Medical Care
PAO Group Inc is the United States-based holding company. It seeks to develop, acquire, partner, or participate in, companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending on patient needs. The... see more

Recent & Breaking News (PINL:PAOG)

PAOG Sets 2021 Cannabis Biopharmaceutical Revenue Goals

PR Newswire January 14, 2021

PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook

Newsfile January 14, 2021

PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow

Newsfile January 13, 2021

PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021

Newsfile January 12, 2021

PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020

Newsfile January 11, 2021

PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition

Newsfile January 8, 2021

PAOG Takes Major CBD Pharmaceutical Development Step Forward

Newsfile January 5, 2021

PAOG Engages Veristat For CRO Services To Advance CBD COPD Treatment

PR Newswire January 5, 2021

PAOG Expects to Report First Post Acquisition Revenue in Q4 2020

Newsfile December 22, 2020

PAOG Develops CBD Nutraceutical for $12.7 Billion from Patented Extract Process

Newsfile December 18, 2020

PAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product Line

PR Newswire December 18, 2020

PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution

Newsfile December 17, 2020

PURA with ALKM and PAOG Celebrate U.S. House Of Representatives Vote To End Marijuana Prohibition

Newsfile December 4, 2020

PURA - Encourages Everyone to Email Congress Today in Support of Marijuana Opportunity Reinvestment and Expungement Act

Newsfile December 4, 2020

PURA with PAOG and ALKM Partners Prepare for Anticipated Benefits From Marijuana Opportunity Reinvestment and Expungement Act

Newsfile December 3, 2020

PAOG CEO Discusses 2020 Progress And PURA Dividend On MoneyTV

Newsfile November 25, 2020

This Week on MoneyTV with Donald Baillargeon, 11/25

Accesswire November 25, 2020

PURA and ALKM Cement Innovative Hemp Marketing Partnership With Equity Stake

PR Newswire November 23, 2020

PAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend Distribution

PR Newswire November 17, 2020

PAOG Publishes First Financial Report Following Two Strategic Acquisitions

Newsfile November 17, 2020